Diagnostic significance of highly sensitive troponins in cardiac surgery

Cover Page

Cite item

Full Text

Abstract

Background: The level of troponins after cardiac surgery always exceeds the reference values, however, the interpretation of these changes is difficult. Aim: To determine the relationship between the high-sensitivity cardiac troponin I and troponin T levels and the risk of heart failure (HF) development within 24 hours after the heart surgery. Methods: A prospective, observational, single-center study included 70 patients undergoing elective heart surgery. The patients were retrospectively divided into two groups based on the development of HF in the first 12 hours after the surgery. The group without HF included 57 patients, the group with HF included 13 patients. Results: The levels of highly sensitive Troponin I (HsTI) in patients who underwent elective heart surgery without complications were 61 times higher than the upper limit of the normal values, in those with the development of HF they were 111 times higher than the upper limit of the normal values. The levels of highly sensitive Troponin T (HsTT) were 25.5 times and 51 times the upper limit of the normal values, respectively. The level of HsTI at the end of the surgery can be a predictor of the HF development, regardless of the use of cardiac bypass (threshold value =1483 ng/l), as well as a predictor of the need for inotropic support for 2 days or more, regardless of the operation type (threshold value = 1573 ng/l). There was a direct moderate correlation of the HsTI level at the end of the operation and 6 hours after the operation with cumulative hemohydrobalance for 24 hours, which was 60% higher in patients with HF than that in patients without complications. Conclusion: In uncomplicated patients, the level of highly sensitive troponins T and I in the postoperative period is 25–61 times higher than the upper limit of the normal values, and with the HF development it is 51–111 times higher. Highly sensitive troponins can be considered as predictors of the HF development and the duration of inotropic support. The increase in the level of troponins is influenced by the duration of cardiac bypass and the volume of infusion therapy in the perioperative period.

About the authors

Irina M. Yanovskaya

Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency

Email: for136106@yandex.ru
ORCID iD: 0000-0001-8578-4710
Russian Federation, 28, Orekhovy blvd, Moscow, 115682

Irina A. Mandel

Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency; The First Sechenov Moscow State Medical University (Sechenov University)

Email: irina.a.mandel@gmail.com
ORCID iD: 0000-0001-9437-6591

MD, PhD

Russian Federation, 28, Orekhovy blvd, Moscow, 115682; Moscow

Tatiana V. Klypa

Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency

Email: tvklypa@gmail.com
ORCID iD: 0000-0002-2732-967X
SPIN-code: 2349-8980

MD, PhD

Russian Federation, 28, Orekhovy blvd, Moscow, 115682

Nadezhda A. Kolyshkina

Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency

Email: baklab_83@mail.ru
ORCID iD: 0000-0003-4486-5412
Russian Federation, 28, Orekhovy blvd, Moscow, 115682

Iliya S. Marey

Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency

Email: asystoliya@yandex.ru
ORCID iD: 0000-0001-6133-7190
Russian Federation, 28, Orekhovy blvd, Moscow, 115682

Alexander S. Zotov

Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency

Email: zotov.alex.az@gmail.com
ORCID iD: 0000-0003-0494-0211
SPIN-code: 9315-6570

MD, PhD

Russian Federation, 28, Orekhovy blvd, Moscow, 115682

Vladimir P. Baklaushev

Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency; Pulmonology Scientific Research Institute under Federal Medical and Biological Agency of Russian Federation

Author for correspondence.
Email: baklaushev.vp@fnkc-fmba.ru
ORCID iD: 0000-0003-1039-4245
SPIN-code: 3968-2971

MD, PhD

Russian Federation, 28, Orekhovy blvd, Moscow, 115682; Moscow

References

  1. Мареев В.Ю., Фомин И.В., Агеев Ф.Т., и др. Клинические рекомендации ОССН–РКО–РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика, профилактика и лечение // Кардиология. 2018. Т. 58, № 6S. С. 8–158. [Mareev VYu, Fomin IV, Ageev FT, et al. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiia. 2018;58(6S):8–158. (In Russ).] doi: 10.18087/cardio.2475
  2. Lippi G, Cervellin G, Sanchis-Gomar F. Predicting mortality with cardiac troponins: recent insights from meta-analyses. Diagnosis (Berl). 2019;8(1):37–49. doi: 10.1515/dx-2019-0061
  3. Ammirati E, Dobrev D. Conventional troponin-I versus high-sensitivity troponin-T: performance and incremental prognostic value in non-ST-elevation acute myocardial infarction patients with negative CK-MB based on a real-world multicenter cohort. Int J Cardiol Heart Vasc. 2018;20:38–39. doi: 10.1016/j.ijcha.2018.07.002
  4. Noordzij PG, van Geffen O, Dijkstra IM, et al. High-sensitive cardiac troponin T measurements in prediction of non-cardiac complications after major abdominal surgery. Br J Anaesth. 2015;114(6):909–918. doi: 10.1093/bja/aev027
  5. Welsh P, Preiss D, Hayward C, et al. Cardiac troponin T and troponin I in the general population. Circulation. 2019;139(24): 2754–2764. doi: 10.1161/CIRCULATIONAHA.118.038529
  6. Plicner D, Stoliński J, Wąsowicz M, et al. Preoperative values of inflammatory markers predict clinical outcomes in patients after CABG, regardless of the use of cardiopulmonary bypass. Indian Heart J. 2016;68(Suppl 3):S10–S15. doi: 10.1016/j.ihj.2016.10.002
  7. Mebazaa A, Pitsis AA, Rudiger A, et al. Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care. 2010;14(2):201. doi: 10.1186/cc8153
  8. Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology. 2002;97(1):215–252. doi: 10.1097/00000542-200207000-00030
  9. Thygesen K, Alpert JS, Jaffe AS, et al. Executive Group on behalf of the Joint European Society of Cardiology (ESC) / American College of Cardiology (ACC) / American Heart Association (AHA) / World Heart Federation (WHF) task force for the universal definition of myocardial infarction. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–2264. doi: 10.1016/j.jacc.2018.08.1038
  10. Garcia-Garcia HM, McFadden EP, Farb A, et al. Academic research consortium. Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document. Eur Heart J. 2018;39(23):2192–2207. doi: 10.1093/eurheartj/ehy223
  11. Devereaux PJ, Lamy A, Chan MT, et al. High-sensitivity troponin I after cardiac surgery and 30-day mortality. N Engl J Med. 2022;386(9):827–836. doi: 10.1056/NEJMoa2000803
  12. Gualandro DM, Puelacher C, Lurati Buse G, et al. Incidence and outcomes of perioperative myocardial infarction/injury diagnosed by high-sensitivity cardiac troponin I. Clin Res Cardiol. 2021;110(9):1450–1463. doi: 10.1007/s00392-021-01827-w
  13. Petäjä L, Røsjø H, Mildh L, et al. Predictive value of high-sensitivity troponin T in addition to EuroSCORE II in cardiac surgery. Interact Cardiovasc Thorac Surg. 2016;23(1):133–141. doi: 10.1093/icvts/ivw060
  14. Vikenes K, Andersen KS, Melberg T, et al. Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms. Am J Cardiol. 2010;106(6):780–786. doi: 10.1016/j.amjcard.2010.04.038
  15. Al-Fares A, Pettenuzzo T, del Sorbo L. Extracorporeal life support and systemic inflammation. Intensive Care Med Exp. 2019; 7(Suppl 1):46. doi: 10.1186/s40635-019-0249-y
  16. Gao XM, Su Y, Moore S, et al. Relaxin mitigates microvascular damage and inflammation following cardiac ischemia-reperfusion. Basic Res Cardiol. 2019;114(4):30. doi: 10.1007/s00395-019-0739-9
  17. Farstad M, Heltne JK, Rynning SE, et al. Fluid extravasation during cardiopulmonary bypass in piglets--effects of hypothermia and different cooling protocols. Acta Anaesthesiol Scand. 2003;47(4):397–406. doi: 10.1034/j.1399-6576.2003.00103.x
  18. Li C, Wang H, Liu N, et al. Early negative fluid balance is associated with lower mortality after cardiovascular surgery. Perfusion. 2018;33(8):630–637. doi: 10.1177/0267659118780103
  19. Samoni S, Vigo V, Reséndiz LI, et al. Impact of hyperhydration on the mortality risk in critically ill patients admitted in intensive care units: comparison between bioelectrical impedance vector analysis and cumulative fluid balance recording. Crit Care. 2016;20:95. doi: 10.1186/s13054-016-1269-6

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Types of surgical interventions, n.

Download (1MB)
3. Fig. 2. Dynamics of troponins I and T in patients with/without heart failure after surgery. With heart failure blue line, without — grey line.

Download (1MB)
4. Fig. 3. Prediction of inotropic support for 2 days or longer according to the level of high-sensitivity Troponin I at the end of the surgery, regardless of its type.

Download (942KB)

Copyright (c) 2022 Yanovskaya I.M., Mandel I.A., Klypa T.V., Kolyshkina N.A., Marey I.S., Zotov A.S., Baklaushev V.P.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies